EUS-FNA versus EUS-FNB in Pancreatic Solid Lesions ≤ 15 mm
Diagnostics · 15.02.2024 · 14 (4) · 427
DOI: 10.3390/diagnostics14040427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 15.02.2024. Verfasst von Maria Cristina Conti Bellocchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Interventional Endoscopy of the Pancreas, Pancreas Institute, G.B. Rossi University Hospital, 37134 Verona, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A small tumor size may impact the diagnostic performance of endoscopic ultrasound-guided tissue acquisition (EUS-TA) for diagnosing solid pancreatic lesions (SPLs). We aimed to compare the diagnostic yield of EUS-guided fine-needle aspiration (FNA) and biopsy (FNB) in SPLs with a diameter ≤ 15 mm. Consecutive patients who underwent EUS-TA for SPLs ≤ 15 mm between January 2015 and December 2022 in a tertiary referral center were retrospectively evaluated. The primary endpoint was diagnostic accuracy. The final diagnosis was based on surgical pathology or disease evolution after a minimum follow-up of 6 months. Inadequate samples were all considered false negatives for the study. Secondary outcomes included sample adequacy, factors impacting accuracy, and safety. We included 368 patients (52.4% male; mean age: 60.2 years) who underwent FNA in 72 cases and FNB in 296. The mean size of SPLs was 11.9 ± 2.6 mm. More than three passes were performed in 5.7% and 61.5% of patients in the FNB and FNA groups, respectively (p < 0.0001). FNB outperformed FNA in terms of diagnostic accuracy (89.8% vs. 79.1%, p = 0.013) and sample adequacy (95.9% vs. 86.1%, p < 0.001). On multivariate analysis, using FNA (OR: 2.10, 95% CI: 1.07–4.48) and a final diagnosis (OR: 3.56, 95% CI: 1.82–6.94) of benign conditions negatively impacted accuracy. Overall, the adverse event rate was 0.8%, including one pancreatitis in the FNA group and one pancreatitis and one bleeding in the FNB group, all mild and conservatively managed. EUS-TA for SPLs ≤ 15 mm has a high diagnostic yield and safety. This study suggests the superiority of FNB over FNA, with better performance even with fewer passes performed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diagnostic and Interventional Endoscopy of the Pancreas, Pancreas Institute, G.B. Rossi University Hospital, 37134 Verona, Italy.
- Department of Medicine, Pancreas Institute, G.B. Rossi University Hospital, 37134 Verona, Italy.
ORCID-Profile: Maria Cristina Conti Bellocchi, Antonio Amodio, Nicolò De Pretis, Luca Frulloni, Stefano Francesco Crinò
Zitieren
APA
Conti Bellocchi, M. C., Bernuzzi, M., Brillo, A., Bernardoni, L., Amodio, A., De Pretis, N., Frulloni, L., Gabbrielli, A., & Crinò, S. F. (2024). EUS-FNA versus EUS-FNB in Pancreatic Solid Lesions ≤ 15 mm. Diagnostics, 14(4), 427. https://doi.org/10.3390/diagnostics14040427
Vancouver
Conti Bellocchi MC, Bernuzzi M, Brillo A, Bernardoni L, Amodio A, De Pretis N, et al. EUS-FNA versus EUS-FNB in Pancreatic Solid Lesions ≤ 15 mm. Diagnostics. 2024;14(4):427. doi:10.3390/diagnostics14040427
BibTeX
@article{ContiBellocchi2024,
author = {Conti Bellocchi, Maria Cristina and Bernuzzi, Micol and Brillo, Alessandro and Bernardoni, Laura and Amodio, Antonio and De Pretis, Nicolò and Frulloni, Luca and Gabbrielli, Armando and Crinò, Stefano Francesco},
title = {EUS-FNA versus EUS-FNB in Pancreatic Solid Lesions ≤ 15 mm},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {4},
pages = {427},
doi = {10.3390/diagnostics14040427}
}
EUVIMED